HeartBeat.bio AG to Reinvent Cardiac Drug Discovery
About IMBA IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - is one of the leading biomedical research institutes in Europe focusing on cutting-edge stem cell technologies, functional genomics, and RNA biology. IMBA is located at the Vienna BioCenter, a vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a subsidiary of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research. The stem cell and organoid research at IMBA is being funded by the Austrian Federal Ministry of Science and the City of Vienna.
About red-stars.com data AG red-stars.com data AG is an operative holding company engaged in the global penetration of highly scalable innovative technologies, utilizing and commercializing scientific IP and software.
IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences Vienna Biocenter 3, Dr. Bohr Gasse 3, A-1030 Vienna, Austria Lea-Louisa Klement, M.A., Scientific Office & Event Coordinator Phone: +43 1 79044 - 4804 Email: email@example.com
For Press Enquiries:
MC Services AG Julia von Hummel, Andreas Jungfer Phone: +49 89 210 228-0 Shaun Brown Phone: +44 20 71485998 Email: firstname.lastname@example.org
04.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: HeartBeat.bio AG Dr. Bohr Gasse 7 1030 Wien
Austria E-mail: email@example.com Internet: https://heartbeat.bio/ EQS News ID: 1192262 ? End of News DGAP News Service